The store will not work correctly when cookies are disabled.
N-hexyl-3-methyl-1H-pyrazolo[4,3-d]pyrimidin-7-amine
ID: ALA4209910
PubChem CID: 16638404
Max Phase: Preclinical
Molecular Formula: C12H19N5
Molecular Weight: 233.32
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CCCCCCNc1ncnc2c(C)n[nH]c12
Standard InChI: InChI=1S/C12H19N5/c1-3-4-5-6-7-13-12-11-10(14-8-15-12)9(2)16-17-11/h8H,3-7H2,1-2H3,(H,16,17)(H,13,14,15)
Standard InChI Key: SOQNFAQPKAADMI-UHFFFAOYSA-N
Molfile:
RDKit 2D
17 18 0 0 0 0 0 0 0 0999 V2000
23.1936 -17.2394 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.1925 -18.0589 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.9005 -18.4679 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.8987 -16.8305 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.6073 -17.2358 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.6121 -18.0544 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.3922 -18.3029 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.8695 -17.6377 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.3844 -16.9783 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.6492 -19.0786 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.8963 -16.0133 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.1874 -15.6069 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.4809 -16.0176 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.7719 -15.6111 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.0655 -16.0218 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.3565 -15.6153 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.6500 -16.0260 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 5 1 0
7 10 1 0
4 11 1 0
11 12 1 0
12 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
16 17 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 233.32 | Molecular Weight (Monoisotopic): 233.1640 | AlogP: 2.65 | #Rotatable Bonds: 6 |
Polar Surface Area: 66.49 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 10.95 | CX Basic pKa: 1.77 | CX LogP: 2.17 | CX LogD: 2.17 |
Aromatic Rings: 2 | Heavy Atoms: 17 | QED Weighted: 0.75 | Np Likeness Score: -1.20 |
References
1. Cherukupalli S, Hampannavar GA, Chinnam S, Chandrasekaran B, Sayyad N, Kayamba F, Reddy Aleti R, Karpoormath R.. (2018) An appraisal on synthetic and pharmaceutical perspectives of pyrazolo[4,3-d]pyrimidine scaffold., 26 (2): [PMID:29273417] [10.1016/j.bmc.2017.10.012] |